Bryan K Phillips's Net Worth
$5.39 Million
Who is Bryan K Phillips?
Bryan K Phillips has an estimated net worth of $5.39 Million. This is based on reported shares across multiple companies, which include Inspire Medical Systems, Inc., SURMODICS INC, and Cerevel Therapeutics Holdings, Inc..
SEC CIK
Bryan K Phillips's CIK is 0001412895
Past Insider Trading and Trends
2008 was Bryan K Phillips's most active year for acquiring shares with 5 total transactions. Bryan K Phillips's most active month to acquire stocks was the month of October. 2018 was Bryan K Phillips's most active year for disposing of shares, totalling 10 transactions. Bryan K Phillips's most active month to dispose stocks was the month of October. 2016 saw Bryan K Phillips paying a total of $394,899.30 for 40,966 shares, this is the most they've acquired in one year. In 2018 Bryan K Phillips cashed out on 52,751 shares for a total of $1,573,485.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inspire Medical Systems, Inc. (INSP) Snapshot price: $210.5
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +143.53% | 2.69K |
—
|
—
| 4.57K |
Feb 9
| |||
Form 4
| -9.85% | -205.00 |
$216.61 | -$44,405.05 | 1.88K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -9.47% | -205.00 |
$253.24 | -$51,914.20 | 1.96K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| -9.01% | -205.00 |
$208.00 | -$42,640.00 | 2.07K |
Jan 29
| |||
Form 4
|
∞
| 2.27K |
—
|
—
| 2.27K |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SURMODICS INC (SRDX) Snapshot price: $38.83
SVP, Gen Counsel & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.08% | -1.50K |
$40.93 | -$61,519.62 | 35.31K |
Nov 27 - Nov 30
| |||
Form 4
| +13.12% | 4.27K |
$42.00 | -$150,402.00 | 36.81K |
Nov 25
| |||
Form 4
| -2.23% | -743.00 |
$60.59 | -$25,023.67 | 32.54K |
Nov 30
| |||
Form 4
| +25.20% | 6.7K |
$57.14 | -$266,252.21 | 33.29K |
Nov 27 - Nov 28
| |||
Form 4
| -1.12% | -300.00 |
—
|
—
| 26.59K |
Aug 29
| |||
Form 4
| -35.81% | -15.00K |
$51.72 | -$775,793.20 | 26.89K |
Scheduled
|
Jun 6
| ||
Form 4
| +14.23% | 5.22K |
$27.91 | -$169,637.03 | 41.89K |
Apr 10
| |||
Form 4
| +25.54% | 7.46K |
$33.19 | -$118,878.80 | 36.67K |
Nov 28 - Nov 30
| |||
Form 4
| -4.03% | -1.23K |
$24.85 | -$30,469.29 | 29.21K |
Scheduled
|
Jun 16
| ||
Form 4
| +15.03% | 3.98K |
$23.93 | -$86,570.14 | 30.43K |
Scheduled
|
Nov 30 - Dec 2
| ||
Form 4
| +4.37% | 1.11K |
$25.68 | -$14,897.34 | 26.46K |
Aug 1
| |||
Form 4
| -6.68% | -1.82K |
$23.44 | -$42,560.87 | 25.35K |
Scheduled
|
Jun 14
| ||
Form 4
| +15.48% | 3.64K |
$20.25 | -$37,320.75 | 27.17K |
Dec 17
| |||
Form 4
| -8.42% | -2.16K |
$18.08 | -$253,029.03 | 23.52K |
Scheduled
|
May 21 - May 22
| ||
Form 4
| +58.24% | 9.45K |
$21.03 | -$100,628.55 | 25.69K |
Dec 2
| |||
Form 4
| -17.82% | -3.52K |
$16.75 | -$523,582.78 | 16.23K |
Scheduled
|
Dec 3 - Dec 4
| ||
Form 4
| +267.79% | 14.38K |
$22.58 | -$164,314.66 | 19.75K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| -26.69% | -1.96K |
$16.62 | -$32,492.10 | 5.37K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
| -8.20% | -654.00 |
$10.93 | -$7,148.22 | 7.33K |
Sep 19
| |||
Form 4
| +299.00% | 5.98K |
—
|
—
| 7.98K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| -43.29% | -1.53K |
$23.96 | -$36,580.65 | 2K |
Nov 16
| |||
Form 4
| +76.35% | 1.53K |
$24.25 | -$17,969.25 | 3.53K |
Nov 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerevel Therapeutics Holdings, Inc. (CERE) No price found
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||